Pre-IDE Submission: Clinical Protocol 
Neuroblastoma Bone Marrow Purging System 
BAXTER HEALTHCARE CORPORATION, HYLAND DIVISION 
10. I understand that the information obtained will be kept confidential but that supervised 
review by approved medical representatives of outside institutions or agencies may occur. 
In particular, the chart may be reviewed by an agent of the Food and Drug 
Administration, the National Cancer Institute, or the study sponsor. 
11. I understand that if I have further questions regarding this study /treatment, or concern 
about injury from this study/treatment, I can contact Dr. Victor M. Santana or Dr. 
Malcolm K. Brenner at 901-522-0300. 
12. I understand that further information regarding my (my child’s) rights as a research 
participant can be obtained by contacting the Chairman of the Clinical Trials Committee 
at 901-522-0300. 
13. I understand that I shall receive a signed copy of this informed consent. 
Patient Parent or Guardian 
Physician Witness 
Date 
Recombinant DNA Research, Volume 16 
[495] 
